STARD13 Antikörper (AA 516-679)
Kurzübersicht für STARD13 Antikörper (AA 516-679) (ABIN7170700)
Target
Alle STARD13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 516-679
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human StAR-related lipid transfer protein 13 protein (516-679AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IF:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
-
Andere Bezeichnung
- STARD13
-
Hintergrund
-
Background: GTPase-activating protein for RhoA, and perhaps for Cdc42. May be involved in regulation of cytoskeletal reorganization, cell proliferation and cell motility. Acts a tumor suppressor in hepatocellular carcinoma cells.
Aliases: 46H23.2 antibody, ARHGAP37 antibody, Deleted in liver cancer 2 protein antibody, Deleted in liver cancer protein 2 antibody, DLC-2 antibody, DLC2 antibody, GT650 antibody, Rho GTPase activating protein on chromosome 13q12 antibody, Rho GTPase-activating protein antibody, STA13 antibody, STA13_HUMAN antibody, StAR related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer protein 13 antibody, StARD13 antibody, START domain-containing protein 13 antibody
-
UniProt
- Q9Y3M8
Target
-